Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2403793 | 0.91 | THRB (0.53) | ACHETHRBTSHR | |
| SCHEMBL13872030 | 0.91 | THRB (0.53) | ACHETHRBTSHR | |
| SCHEMBL3821239 | 0.91 | THRB (0.51) | ACHETHRBTSHRCHRNB2CHRNB4 | |
| SCHEMBL21404625 | 0.91 | THRB (0.51) | ACHETHRBTSHRCHRNB2CHRNB4 | |
| SCHEMBL14998171 | 0.90 | ACHE (0.51) | ACHETHRBTSHRCHRNB2CHRNB4 | |
| SCHEMBL21404666 | 0.89 | THRB (0.53) | ACHETHRBTSHRCHRNB2CHRNB4 | |
| SCHEMBL21404715 | 0.89 | THRB (0.53) | ACHETHRBTSHRCHRNB2CHRNB4 | |
| SCHEMBL26735492 | 0.89 | ACHE (0.58) | ACHETHRBTSHR | |
| SCHEMBL92093 | 0.88 | THRB (0.43) | ACHETHRBTSHR | |
| SCHEMBL14984891 | 0.88 | THRB (0.46) | ACHETHRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200057370-A1 | COMPOUND, RESIST COMPOSITION CONTAINING COMPOUND AND PATTERN FORMATION METHOD USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-02-20 | — | — | US | disclosed |
| US-8454689-B2 | Brush copolymers | BAUSCH & LOMB INCORPORATED (US) | 2013-06-04 | — | — | US | disclosed |
| US-8426490-B2 | Methacrylate based monomers containing a urethane linkage, process for production and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-23 | — | — | US | disclosed |
| US-20120107530-A1 | Printing paper for printing stereoscopic image, stereoscopic image printed matter, and method for providing stereoscopic image | FUJIFILM CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| WO-2011040628-A1 | COLORANT MULTIMER, COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING THE SAME, AND SOLID-STATE IMAGE SENSOR, IMAGE DISPLAY DEVICE, LIQUID CRYSTAL DISPLAY DEVICE AND ORGANIC EL DISPLAY WITH THE COLOR FILTER | FUJIFILM CORPORATION (JP) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011005937-A2 | MONO ETHYLENICALLY UNSATURATED POLYMERIZABLE GROUP CONTAINING POLYCARBOSILOXANE MONOMERS | BAUSCH & LOMB INCORPORATED (US) | 2011-01-13 | — | — | WO | disclosed |
| US-20100168852-A1 | Brush Copolymers | SALIX PHARMACEUTICALS, INC. | 2010-07-01 | — | — | US | disclosed |
| US-20100162661-A1 | Packaging Solutions | VALEANT PHARMA POLAND SP. Z O.O. (PL) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200057370-A1 | COMPOUND, RESIST COMPOSITION CONTAINING COMPOUND AND PATTERN FORMATION METHOD USING SAME | CROCC, BICRA, TTC14 | ACHE 3658/4885THRB 4551/4885TSHR 4638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.